Severity
Critical
FDA Drug recall · Reported October 26, 2016
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Sos Telecom Inc. recalled Ninja-X, 4200 mg, 1 capsule per pack, 24 single packs per box. - a critical-severity action.
Ninja-X, 4200 mg, 1 capsule per pack, 24 single packs per box. was recalled by Sos Telecom Inc. in October 26, 2016. Reason: Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and…. Check the official notice for the remedy. Verify recall #D-0102-2017 with the FDA Drug before acting.
The recall
Sos Telecom Inc. issued this critical-severity FDA Drug recall-Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and….
Sourced from official FDA Drug enforcement records. Verify recall #D-0102-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0102-2017) was formally reported on October 26, 2016, with the manufacturer initiating the action on May 12, 2016. It is classified under Critical severity (Class I), with a current status of Terminated. Sos Telecom Inc. is listed as the recalling firm, operating out of Bayside, NY. Federal records list the affected scope as N/A.
The documented reason for this recall is: Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements Distribution data in the federal record shows the product reached: NY. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
N/A
Related Recalls
6
5 from same agency
Ninja-X, 4200 mg, 1 capsule per pack, 24 single packs per box.
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0102-2017 |
| Date reported | October 26, 2016 |
| Date initiated | May 12, 2016 |
| Recalling firm | Sos Telecom Inc. |
| Firm location | Bayside, NY |
| Affected scope | N/A |
| Distribution | NY |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 26, 2016. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.